Suppr超能文献

与一般人群相比,急诊科低高敏肌钙蛋白 T 的长期预后。

Long-term prognosis of low high-sensitivity cardiac troponin T in the emergency department compared with the general population.

机构信息

Department of Emergency and Reparative Medicine, Karolinska University Hospital, Stockholm, Sweden

Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

出版信息

Heart. 2024 Jul 25;110(16):1040-1047. doi: 10.1136/heartjnl-2024-323913.

Abstract

BACKGROUND

Long-term prognosis associated with low-high-sensitivity cardiac troponin T (hs-cTnT) concentrations in patients with chest pain is unknown. We investigated these prognostic implications compared with the general population.

METHODS

All first visits to seven emergency departments (ED)s in Sweden were included from 9 December 2010 to 31 August, 2017 by patients presenting with chest pain and at least one hs-cTnT measured. Patients with myocardial injury (any hs-cTnT >14 ng/L), including patients with myocardial infarction (MI) were excluded. Standardised mortality ratios (SMRs) and standardised incidence ratios (SIRs) were calculated as the ratio of the number of observed to expected events. The expected number was computed by multiplying the 1-year calendar period-specific, age-specific and sex-specific follow-up time in the cohort with the corresponding incidence in the general population. HRs were calculated for all-cause mortality and major adverse cardiovascular events (MACE), defined as acute MI, heart failure hospitalisation, cerebrovascular stroke or cardiovascular death, between patients with undetectable (<5 ng/L) and low (5-14 ng/L) hs-cTnT.

RESULTS

A total of 1 11 916 patients were included, of whom 69 090 (62%) and 42 826 (38%) had peak hs-cTnT concentrations of <5 and 5-14 ng/L. Patients with undetectable peak hs-cTnT had a lower mortality risk compared with the general Swedish population (SMR 0.83, 95% CI 0.79 to 0.87), with lower risks observed in all patients ≥65 years of age, but a slightly higher risk of being diagnosed with a future MI (SIR 1.39, 95% CI 1.32 to 1.47). The adjusted risk of a first MACE associated with low versus undetectable peak hs-cTnT was 1.6-fold (HR 1.61, 95% CI 1.53 to 1.70).

CONCLUSION

Patients with chest pain and undetectable hs-cTnT have an overall lower risk of death compared with the general population, with risks being highly age dependent. Detectable hs-cTnT concentrations are still associated with increased long-term cardiovascular risks.

摘要

背景

目前尚不清楚胸痛患者的高低敏心肌肌钙蛋白 T(hs-cTnT)浓度与长期预后的关系。我们研究了与普通人群相比,这些预后意义。

方法

纳入了 2010 年 12 月 9 日至 2017 年 8 月 31 日期间瑞典 7 家急诊室(ED)首次就诊的所有患者,这些患者均因胸痛就诊且至少测量了一次 hs-cTnT。排除了心肌损伤(任何 hs-cTnT >14ng/L,包括心肌梗死(MI)患者)。标准化死亡率比(SMR)和标准化发病率比(SIR)计算为观察到的事件数与预期事件数的比值。预期数量是通过将队列中特定于 1 年的日历期、年龄和性别随访时间乘以普通人群中的相应发病率来计算的。对于全因死亡率和主要不良心血管事件(MACE),定义为急性 MI、心力衰竭住院、脑血管中风或心血管死亡,计算 hs-cTnT 浓度<5ng/L 和 5-14ng/L 的患者之间的风险比(HR)。

结果

共纳入 111916 例患者,其中 69090(62%)和 42826(38%)例患者 hs-cTnT 峰值浓度<5ng/L 和 5-14ng/L。与普通瑞典人群相比,hs-cTnT 峰值浓度<5ng/L 的患者死亡率较低(SMR 0.83,95%CI 0.79 至 0.87),所有≥65 岁的患者中观察到较低的风险,但未来 MI 的诊断风险略高(SIR 1.39,95%CI 1.32 至 1.47)。与 hs-cTnT 浓度<5ng/L 相比,低 hs-cTnT 浓度与首次 MACE 相关的调整风险为 1.6 倍(HR 1.61,95%CI 1.53 至 1.70)。

结论

与普通人群相比,胸痛且 hs-cTnT 浓度<5ng/L 的患者总体死亡风险较低,风险高度依赖于年龄。可检测的 hs-cTnT 浓度仍然与长期心血管风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2af/11287531/73eeb9eb3e38/heartjnl-2024-323913f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验